O’BRIEN, S. Minimal residual disease elimination by consolidation therapy with alemtuzumab. Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 1, n. 2, 2009. DOI: 10.4081/hmr.v1i2.227. Disponível em: https://www.pagepress.org/journals/hmr/article/view/227. Acesso em: 22 jul. 2024.